Completely 0 10 0 10 O
resected 11 19 11 19 O
NSCLC 20 25 20 25 B-cancer
with 26 30 26 30 O
negative 31 39 31 39 O
margins 40 47 40 47 O
( 48 49 48 49 O
R0 49 51 49 51 O
) 51 52 51 52 O

Completely 0 10 53 63 O
resected 11 19 64 72 O
non 20 23 73 76 B-cancer
- 23 24 76 77 I-cancer
small 24 29 77 82 I-cancer
cell 30 34 83 87 I-cancer
lung 35 39 88 92 I-cancer
cancer 40 46 93 99 I-cancer
with 47 51 100 104 O
negative 52 60 105 113 O
margins 61 68 114 121 O
( 69 70 122 123 O
R0 70 72 123 125 O
) 72 73 125 126 O

Eastern 0 7 127 134 B-clinical_variable
Cooperative 8 19 135 146 I-clinical_variable
Oncology 20 28 147 155 I-clinical_variable
Group 29 34 156 161 I-clinical_variable
( 35 36 162 163 I-clinical_variable
ECOG 36 40 163 167 I-clinical_variable
) 40 41 167 168 I-clinical_variable
performance 42 53 169 180 I-clinical_variable
status 54 60 181 187 I-clinical_variable
0 61 62 188 189 B-lower_bound
- 62 63 189 190 O
1 63 64 190 191 B-upper_bound

No 0 2 192 194 O
locally 3 10 195 202 B-cancer
advanced 11 19 203 211 I-cancer
or 20 22 212 214 O
metastatic 23 33 215 225 B-cancer
cancer 34 40 226 232 I-cancer
requiring 41 50 233 242 O
systemic 51 59 243 251 B-treatment
therapy 60 67 252 259 I-treatment
within 68 74 260 266 O
5 75 76 267 268 B-upper_bound
years 77 82 269 274 I-upper_bound
prior 83 88 275 280 I-upper_bound
to 89 91 281 283 O
registration 92 104 284 296 O

No 0 2 297 299 O
patients 3 11 300 308 O
known 12 17 309 314 O
to 18 20 315 317 O
be 21 23 318 320 O
pregnant 24 32 321 329 B-pregnancy
or 33 35 330 332 O
lactating 36 45 333 342 O

No 0 2 343 345 O
patients 3 11 346 354 O
who 12 15 355 358 O
have 16 20 359 363 O
received 21 29 364 372 O
neoadjuvant 30 41 373 384 B-treatment
therapy 42 49 385 392 I-treatment
( 50 51 393 394 O
chemo- 51 57 394 400 B-treatment
or 58 60 401 403 O
radio 61 66 404 409 B-treatment
- 66 67 409 410 I-treatment
therapy 67 74 410 417 I-treatment
) 74 75 417 418 O
for 76 79 419 422 O
this 80 84 423 427 O
lung 85 89 428 432 B-cancer
cancer 90 96 433 439 I-cancer

No 0 2 440 442 O
patients 3 11 443 451 O
with 12 16 452 456 O
recurrence 17 27 457 467 O
of 28 30 468 470 O
lung 31 35 471 475 B-cancer
cancer 36 42 476 482 I-cancer
after 43 48 483 488 O
prior 49 54 489 494 B-treatment
resection 55 64 495 504 I-treatment

No 0 2 505 507 O
prior 3 8 508 513 B-treatment
treatment 9 18 514 523 I-treatment
with 19 23 524 528 I-treatment
agents 24 30 529 535 I-treatment
targeting 31 40 536 545 O
EGFR 41 45 546 550 B-cancer
mutation 46 54 551 559 I-cancer
, 54 55 559 560 O
ALK 56 59 561 564 B-cancer
rearrangement 60 73 565 578 I-cancer
, 73 74 578 579 O
and 75 78 580 583 O
PD-1 79 83 584 588 O
/ 83 84 588 589 O
PD 84 86 589 591 O
- 86 87 591 592 O
L1 87 89 592 594 O
/ 89 90 594 595 O
CTLA-4 90 96 595 601 O

Pathologic 0 10 602 612 B-clinical_variable
stage 11 16 613 618 I-clinical_variable
IIIA 17 21 619 623 O
, 21 22 623 624 O
II 23 25 625 627 O
( 26 27 628 629 O
IIA 27 30 629 632 O
or 31 33 633 635 O
IIB 34 37 636 639 O
) 37 38 639 640 O
or 39 41 641 643 O
large 42 47 644 649 O
IB 48 50 650 652 O
( 51 52 653 654 O
defined 52 59 654 661 O
as 60 62 662 664 O
size 63 67 665 669 B-clinical_variable
> 68 69 670 671 O
= 69 70 671 672 O
4 71 72 673 674 B-lower_bound
cm 73 75 675 677 I-lower_bound
) 75 76 677 678 O

Pathologic 0 10 679 689 O
stage 11 16 690 695 B-lower_bound
IIIA 17 21 696 700 I-lower_bound
, 21 22 700 701 O
IIA 23 26 702 705 O
or 27 29 706 708 O
IIB 30 33 709 712 B-upper_bound
, 33 34 712 713 O
or 35 37 714 716 O
large 38 43 717 722 O
IB 44 46 723 725 O
( 47 48 726 727 O
defined 48 55 727 734 O
as 56 58 735 737 O
size 59 63 738 742 O
> 64 65 743 744 O
= 65 66 744 745 O
4 67 68 746 747 B-lower_bound
cm 69 71 748 750 I-lower_bound
) 71 72 750 751 O

Suspected 0 9 752 761 O
clinical 10 18 762 770 O
stage 19 24 771 776 O
of 25 27 777 779 O
IIIA 28 32 780 784 B-lower_bound
, 32 33 784 785 O
II 34 36 786 788 O
( 37 38 789 790 O
IIA 38 41 790 793 O
or 42 44 794 796 O
IIB 45 48 797 800 B-upper_bound
) 48 49 800 801 O
or 50 52 802 804 O
large 53 58 805 810 B-upper_bound
IB 59 61 811 813 I-upper_bound
( 62 63 814 815 O
defined 63 70 815 822 O
as 71 73 823 825 O
size 74 78 826 830 O
> 79 80 831 832 O
= 80 81 832 833 O
4 82 83 834 835 B-lower_bound
cm 84 86 836 838 I-lower_bound
) 86 87 838 839 O

Suspected 0 9 840 849 O
diagnosis 10 19 850 859 O
of 20 22 860 862 O
resectable 23 33 863 873 O
non 34 37 874 877 B-cancer
- 37 38 877 878 I-cancer
small 38 43 878 883 I-cancer
cell 44 48 884 888 I-cancer
lung 49 53 889 893 I-cancer
cancer 54 60 894 900 I-cancer

cancers 0 7 901 908 B-cancer
with 8 12 909 913 O
a 13 14 914 915 O
histology 15 24 916 925 O
of 25 27 926 928 O
adenosquamous 28 41 929 942 B-cancer
are 42 45 943 946 O
considered 46 56 947 957 O
a 57 58 958 959 O
type 59 63 960 964 O
of 64 66 965 967 O
adenocarcinoma 67 81 968 982 B-cancer
and 82 85 983 986 O
thus 86 90 987 991 O
a 91 92 992 993 O
nonsquamous 93 104 994 1005 O
histology 105 114 1006 1015 O

no 0 2 1016 1018 O
secondary 3 12 1019 1028 O
primary 13 20 1029 1036 B-cancer
lung 21 25 1037 1041 I-cancer
cancer 26 32 1042 1048 I-cancer
diagnosed 33 42 1049 1058 O
concurrently 43 55 1059 1071 O
or 56 58 1072 1074 O
within 59 65 1075 1081 O
2 66 67 1082 1083 B-upper_bound
year 68 72 1084 1088 I-upper_bound
prior 73 78 1089 1094 I-upper_bound
to 79 81 1095 1097 O
registration 82 94 1098 1110 O

pre 0 3 1111 1114 O
- 3 4 1114 1115 O
surgical 4 12 1115 1123 B-treatment
patients 13 21 1124 1132 O

the 0 3 1133 1136 O
tumor 4 9 1137 1142 B-clinical_variable
size 10 14 1143 1147 I-clinical_variable
is 15 17 1148 1150 O
> 18 19 1151 1152 O
= 19 20 1152 1153 O
4 21 22 1154 1155 B-lower_bound
cm 23 25 1156 1158 I-lower_bound

